EMA Authorised: Fampridine Accord (Fampridine) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Fampridine Accord (fampridine) by Accord Healthcare S.L.U. for use in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine Accord (fampridine)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis. MAH: Accord Healthcare S.L.U.. Decision date: 23/06/2025